ORIC - Rega marang bathi kanthi panyesuaian wutah oricpharma.com

ORIC Pharmaceuticals is carving out a narrow niche in combating tumor resistance, aiming for market dominance should its drug candidates succeed. The scientific foundation enables the creation of combination regimens that bypass cancer cell defenses. Risks are minimized by distributing trials across external laboratories. The ratio of the company's valuation to its growth rate on this chart visualizes the fundamental trend, while the 0.00 indicator confirms the current level.

ORIC: Pangali rega marang bathi tumrap wutah oricpharma.com 04.07.2022 - 10.11.2026

Rincian metrik lan analitis perusahaan ORIC Pharmaceuticals (ORIC)

- nilai pasar lan prakiraan target analis:

Bagan kurs ORIC Pharmaceuticals Inc|ORIC - Target konsensus

- statistik kapitalisasi pasar:

Nilai pasar ORIC Pharma|ORIC - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data nilai buku modal saham:

Nilai Akuntansi Saham ORIC Pharmaceuticals|ORIC - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku oricpharma.com|ORIC - Total Aset Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Total Utang marang Modal ORIC Pharmaceuticals|ORIC - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal oricpharma.com|ORIC - Gunggung utang perusahaan|Utang marang aset resik ORIC Pharma|ORIC - Utang jangka dawa perusahaan|Utang jangka cendhak ORIC Pharmaceuticals|Rasio likuiditas perantara oricpharma.com

- informasi bathi lan kelipatan valuasi:

ORIC - Bathi resik|Bathi resik sing dikarepake ORIC Pharmaceuticals|ORIC - Pangali P/E|Rasio rega marang bathi mangsa ngarep ORIC Corp|ORIC - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan ORIC Pharma|ORIC - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan ORIC Pharmaceuticals|ORIC - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan oricpharma.com|ORIC - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep ORIC Pharmaceuticals

Analisis umum perusahaan:ORIC Pharmaceuticals

Amid market volatility, capital protection requires distinguishing between true undervaluation and business degradation. The focus of ORIC Pharmaceuticals (ORIC) on laboratory safety and clinical trials minimizes operational risks, while the PEG ratio—dividing the P/E by the earnings growth rate—identifies undervalued assets when the value is below one, signaling potential for a sharp surge in share prices.

Perusahaan pesaing

Genmab AS (GMAB) - Rasio rega marang wutah bathi resik|Exelixis Corp - Pangali rega marang bathi tumrap wutah|Nuvalent Therapeutics (NUVL) - Rega marang bathi kanthi panyesuaian wutah|KYMR: Pangali rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah IDYA (ideayabio.com)|ELVN (Enliven Therapeutics, Inc.) - Pangali rega marang bathi tumrap wutah|RLAY: Rasio nilai perusahaan marang wutah bathi|NRIX (Nurix Pharma) - Pangali PEG|Pangali PEG Tyra Corp|Rasio rega marang bathi tumrap wutah Verastem, Inc. (VSTM)|GLUE (monterosatx.com) - Koefisien bali modal nimbang wutah|Pangali PEG CGEM (Cullinan Therapeutics, Inc.)|Rasio rega marang wutah bathi resik Immuneering Corp|C4 Tx - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Black Diamond Therapeutics, Inc|RPTX (Repare Therapeutics) - Pangali rega marang bathi tumrap wutah|PMVP: Rasio nilai perusahaan marang wutah bathi|KPTI (Karyopharm Therapeutics, Inc.) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Propanc Biopharma, Inc. PPCB|Pangali PEG BGMS|aadibio.com - Rasio P/E diaturake wutah|Aileron Therapeutics, Inc. - Pangali rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah BPMC|GLYC: Pangali rega marang bathi tumrap wutah|SpringWorks Therapeutics Inc. - Rasio nilai perusahaan marang wutah bathi